[시장보고서]세계의 In Vivo CRO 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

세계의 In Vivo CRO 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

Global In Vivo CRO Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

상품코드 : 1475162

리서치사 : Value Market Research

발행일 : 2024년 04월

페이지 정보 : 영문 222 Pages

라이선스 & 가격 (부가세 별도)

US $ 3,920

￦ 5,838,000

PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 전자파일의 이용 범위와 동일합니다.

US $ 4,730

￦ 7,044,000

PDF & Excel (10-user License)

PDF 및 Excel 보고서를 동일 기업 내 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 전자파일의 이용 범위와 동일합니다.

US $ 7,430

￦ 11,065,000

PDF & Excel (Corporate User License)

PDF 및 Excel 보고서를 동일 기업 내 모든 사용자가 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 전자파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

In Vivo CRO 시장의 세계 수요는 2023년 50억 6,000만 달러에서 2032년에는 약 101억 9,000만 달러의 시장 규모에 달할 것으로 추정되며, 조사 기간인 2024-2032년 CAGR은 8.09%입니다.

이 조사 리포트는 Porter's Five Forces 모델, 시장의 매력 분석, 밸류체인 분석을 다루고 있습니다. 이 툴은 업계의 구조를 명확하게 파악하고, 세계 레벨에서의 경쟁 매력을 평가하는데 도움이 됩니다. 또한 이 툴은 세계의 In Vivo CRO 시장에서 각 부문을 종합적으로 평가할 수도 있습니다. In Vivo CRO 산업의 성장과 동향은 이 조사에 전체적인 어프로치를 제공하고 있습니다.

시장 세분화

In Vivo CRO 시장 보고서의 이 섹션은, 국가와 지역 레벨 부문에 관한 상세 데이터를 제공하고, 이에 따라 전략가가 향후 기회와 함께 각각의 제품 또는 서비스의 대상층을 식별하는데 도움이 됩니다.

동물 모델별

설치류 기반(래트 모델, 마우스 모델, 기타 설치류 모델)
비설치류 기반

서비스별

바이오 분석 & Dmpk 시험
독성 시험(GLP 독성 시험, 비GLP 독성 시험)
기타

의약품 유형별

저분자 의약품
고분자 의약품(세포·유전자 치료, RNA 치료, 기타)

치료 영역별

암영역
임상 약리학
순환기 영역
감염증
신경학
소화기·간장학
대사·내분비
안과
자가면역/염증성 질환
기타

용도별

제약·바이오 제약기업
의료기기 기업
학술·연구기관

지역별 분석

본 섹션에서는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카에서 In Vivo CRO 시장의 현재와 향후 수요에 관한 지역별 전망을 다룹니다. 또한 유명 전 지역에서 개별 용도 부문의 수요·추정·예측에도 초점을 맞추고 있습니다.

커스텀 요건이 있는 경우, 문의해주시기 바랍니다. Value Market Research의 조사팀이 고객의 요구에 따라 맞춤형 리포트를 제공할 수 있습니다.

지역별 전망
서론
북미 판매 분석
- 개요, 실적과 예측
- 북미 : 부문별
- 북미 : 국가별
- 미국
- 캐나다
- 멕시코
유럽 판매 분석
- 개요, 실적과 예측
- 유럽 : 부문별
- 유럽 : 국가별
- 영국
- 프랑스
- 독일
- 이탈리아
- 러시아
- 기타 유럽
아시아태평양 판매 분석
- 개요, 실적과 예측
- 아시아태평양 : 부문별
- 아시아태평양 : 국가별
- 중국
- 인도
- 일본
- 한국
- 호주
- 동남아시아
- 기타 아시아태평양
라틴아메리카 판매 분석
- 개요, 실적과 예측
- 라틴아메리카 : 부문별
- 라틴아메리카 : 국가별
- 브라질
- 아르헨티나
- 페루
- 칠레
- 기타 라틴아메리카
중동 및 아프리카 판매 분석
- 개요, 실적과 예측
- 중동 및 아프리카 : 부문별
- 중동 및 아프리카 : 국가별 리스트
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카

제11장 In Vivo CRO 기업의 경쟁 구도

In Vivo CRO 시장의 경쟁
제휴·협력·계약
합병·인수
신제품 출시
기타 개발

제12장 기업 개요

상위 기업의 시장 점유율 분석
시장 집중도
Biocytogen
Charles River Laboratories International Inc.
Crown Bioscience
Evotec
GemPharmatech
IQVIA Inc.
Icon Plc
Labcorp Drug Development
Parexel International Corporation
PsychoGenics Inc.
Taconic Biosciences Inc.

KSA

영문 목차

영문목차

The global demand for In Vivo CRO Market is presumed to reach the market size of nearly USD 10.19 Billion by 2032 from USD 5.06 Billion in 2023 with a CAGR of 8.09% under the study period 2024 - 2032.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in vivo cro. The growth and trends of in vivo cro industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the in vivo cro market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Animal Model

Rodent-Based (Rat Models, Mice Models, Other Rodent Models)
Non-Rodent-Based

By Service

Bioanalysis & Dmpk Studies
Toxicity Studies (Glp Toxicology Studies, Non-Glp Toxicology Studies)
Other Services

By Drug Type

Small-Molecule Drugs
Large-Molecule Drugs (Cell & Gene Therapy, Rna Therapy, Other)

By Therapeutic Area

Oncology
Clinical Pharmacology
Cardiology
Infectious Diseases
Neurology
Gastroenterology & Hepatology
Metabolic & Endocrine
Ophthalmology
Autoimmune / Inflammatory Conditions
Other

By End-Use

Pharmaceutical & Biopharmaceutical Companies
Medical Device Companies
Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the In Vivo CRO market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In Vivo CRO market include Biocytogen, Charles River Laboratories International Inc., Crown Bioscience, Evotec, GemPharmatech, IQVIA Inc., Icon Plc, Labcorp Drug Development, Parexel International Corporation, PsychoGenics Inc., Taconic Biosciences, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. IN VIVO CRO - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Animal Model
- 3.7.2 Market Attractiveness Analysis By Service
- 3.7.3 Market Attractiveness Analysis By Drug Type
- 3.7.4 Market Attractiveness Analysis By Therapeutic Area
- 3.7.5 Market Attractiveness Analysis By End-use
- 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL IN VIVO CRO MARKET ANALYSIS BY ANIMAL MODEL

5.1. Overview By Animal Model
5.2. Historical and Forecast Data
5.3. Analysis By Animal Model
5.4. Rodent-Based (Rat Models, Mice Models, Other Rodent Models) Historic and Forecast Sales By Regions
5.5. Non-Rodent-Based Historic and Forecast Sales By Regions

6. GLOBAL IN VIVO CRO MARKET ANALYSIS BY SERVICE

6.1. Overview By Service
6.2. Historical and Forecast Data
6.3. Analysis By Service
6.4. Bioanalysis & DMPK Studies Historic and Forecast Sales By Regions
6.5. Toxicity Studies (GLP Toxicology Studies, Non-GLP Toxicology Studies) Historic and Forecast Sales By Regions
6.6. Other Services Historic and Forecast Sales By Regions

7. GLOBAL IN VIVO CRO MARKET ANALYSIS BY DRUG TYPE

7.1. Overview By Drug Type
7.2. Historical and Forecast Data
7.3. Analysis By Drug Type
7.4. Small-Molecule Drugs Historic and Forecast Sales By Regions
7.5. Large-Molecule Drugs (Cell & Gene Therapy, RNA Therapy, Other) Historic and Forecast Sales By Regions

8. GLOBAL IN VIVO CRO MARKET ANALYSIS BY THERAPEUTIC AREA

8.1. Overview By Therapeutic Area
8.2. Historical and Forecast Data
8.3. Analysis By Therapeutic Area
8.4. Oncology Historic and Forecast Sales By Regions
8.5. Clinical Pharmacology Historic and Forecast Sales By Regions
8.6. Cardiology Historic and Forecast Sales By Regions
8.7. Infectious Diseases Historic and Forecast Sales By Regions
8.8. Neurology Historic and Forecast Sales By Regions
8.9. Gastroenterology & Hepatology Historic and Forecast Sales By Regions
8.10. Metabolic & Endocrine Historic and Forecast Sales By Regions
8.11. Ophthalmology Historic and Forecast Sales By Regions
8.12. Autoimmune / Inflammatory Conditions Historic and Forecast Sales By Regions
8.13. Other Historic and Forecast Sales By Regions

9. GLOBAL IN VIVO CRO MARKET ANALYSIS BY END-USE

9.1. Overview By End-use
9.2. Historical and Forecast Data
9.3. Analysis By End-use
9.4. Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales By Regions
9.5. Medical Device Companies Historic and Forecast Sales By Regions
9.6. Academic & Research Institutes Historic and Forecast Sales By Regions

10. GLOBAL IN VIVO CRO MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE IN VIVO CRO COMPANIES

11.1. In Vivo CRO Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12. COMPANY PROFILES OF IN VIVO CRO INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Market Concentration Rate
12.3. Biocytogen
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
12.4. Charles River Laboratories International Inc.
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
12.5. Crown Bioscience
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
12.6. Evotec
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments
12.7. GemPharmatech
- 12.7.1 Company Overview
- 12.7.2 Company Revenue
- 12.7.3 Products
- 12.7.4 Recent Developments
12.8. IQVIA Inc.
- 12.8.1 Company Overview
- 12.8.2 Company Revenue
- 12.8.3 Products
- 12.8.4 Recent Developments
12.9. Icon Plc
- 12.9.1 Company Overview
- 12.9.2 Company Revenue
- 12.9.3 Products
- 12.9.4 Recent Developments
12.10. Labcorp Drug Development
- 12.10.1 Company Overview
- 12.10.2 Company Revenue
- 12.10.3 Products
- 12.10.4 Recent Developments
12.11. Parexel International Corporation
- 12.11.1 Company Overview
- 12.11.2 Company Revenue
- 12.11.3 Products
- 12.11.4 Recent Developments
12.12. PsychoGenics Inc.
- 12.12.1 Company Overview
- 12.12.2 Company Revenue
- 12.12.3 Products
- 12.12.4 Recent Developments
12.13. Taconic Biosciences Inc.
- 12.13.1 Company Overview
- 12.13.2 Company Revenue
- 12.13.3 Products
- 12.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies